CSS
CLYM

Cubist Systematic Strategies’s Climb Bio CLYM Stock Holding History

Cubist Systematic Strategies’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$77.6K Sell
38,591
-23,585
-38% -$43.8K ﹤0.01% 2804
2025
Q2 		$77.1K Buy
+62,176
New +$77.4K ﹤0.01% 2739
2022
Q2 		– Sell
-638
Closed -$5K – 4612
2022
Q1 		$5K Buy
+638
New +$5.95K ﹤0.01% 3507

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cubist Systematic Strategies's CLYM Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Climb Bio (CLYM) stake by 38% in Q3 2025, selling an estimated $43.8K and leaving 38,591 shares worth $77.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Cubist Systematic Strategies first reported a position in CLYM in Q1 2022 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold CLYM as of Q3 2025.

  • Cubist Systematic Strategies held 38,591 shares of Climb Bio worth $77.6K as of Q3 2025.
  • Cubist Systematic Strategies sold 23,585 Climb Bio shares in Q3 2025, an estimated $43.8K.
  • Climb Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2804 holding.
  • Cubist Systematic Strategies first reported a position in Climb Bio in Q1 2022 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Climb Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.